A doctor and a patient discussing a therapy plan that includes pharmaceutical products. GSK plc (NYSE:GSK), formerly known as GlaxoSmithKline, is a global pharmaceutical and healthcare corporation ...

After a year of controversy and complaints, Sen. Elizabeth Warren is asking a federal watchdog to investigate GSK over its ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

The court directed the firm to pay Ms Gichuki 10 months’ salary as compensation would be adequate in the circumstances ...

A scientist working in Switzerland has become the fifth person to be convicted of attempting to steal trade secrets from pharmaceutical ... attempted to re-brand GSK products under development ...

The annual per capita pharmaceutical sales are less than US$32. Most of this spent is out of the pocket. By providing a big portfolio of 140 products with a relative low price, GSK is winning the ...

The company reported strong performance across key product portfolios ... In the vaccines segment, GlaxoSmithKline Pharmaceuticals maintained leadership in the self-pay private market for ...

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary ... Also, they introduced the Animal health products. In the year 1971, the company built the Research & development laboratory at Thane.

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against the other ...

The company anticipates five new product approvals in 2025 ... sales target to over £40 billion. Overall GSK ranks 5th on our list of the cheap pharmaceutical stocks to buy according to analysts.